Literature DB >> 30173734

Effect of annexin II-mediated conversion of plasmin from plasminogen on airborne transmission of H9N2 avian influenza virus.

Hailong Su1, Xueqin Yang2, Shifeng Wang3, Huoying Shi4, Xiufan Liu5.   

Abstract

Airborne transmission plays an important role in dissemination of H9N2 subtype avian influenza virus. Annexin II (A2)-mediated activation of plasminogen (PLG) promotes cleavage of the influenza virus HA protein and viral replication, resulting in enhanced pathogenesis. In this study, airborne transmission competent and defective strains of H9N2 influenza virus, SH7 and SH14, respectively, were used to investigate the effect of A2 on airborne spread. The results showed that A2 protein was increased in SH7 virions compared with SH14 particles, the binding ability of the SH7-infected MDCK cells to PLG was significantly higher than the SH14-infected cells, and influence efficiency of the PLG on replicated ability of SH7 virus was significantly stronger than that of SH14 virus, who spread without airborne route, indicating that the annexin 2 (A2) can bind PLG and contributes to SH7 with high replication ability. Furthermore, the copies of SH7 in the airborne infected chickens under inhibited by 6-AHA were significantly decreased, suggesting that the release of H9N2 avian influenza virus were reduced by inhibiting the conversion of PLG to PL, ultimately resulting in reduced airborne transmission of H9N2 avian influenza virus. In summary, A2-mediated conversion of PLG to PL plays a role in the airborne transmission capacity of H9N2 avian influenza viruses, and this interaction may represent potential targets for prevention and treatment of influenza virus infection.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airborne transmission; Annexin II; Avian influenza virus; H9N2; Plasminogen

Mesh:

Substances:

Year:  2018        PMID: 30173734     DOI: 10.1016/j.vetmic.2018.08.002

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Adaptive amino acid substitutions enable transmission of an H9N2 avian influenza virus in guinea pigs.

Authors:  Liu Lina; Chen Saijuan; Wang Chengyu; Lu Yuefeng; Dong Shishan; Chen Ligong; Guo Kangkang; Guo Zhendong; Li Jiakai; Zhang Jianhui; Luo Qingping; Zhang Wenting; Shang Yu; Wang Honglin; Zhang Tengfei; Wen Guoyuan; Zhu Jiping; Zhang Chunmao; Jin Meilin; Gao Yuwei; Shao Huabin; Zhao Zongzheng
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

2.  Dual Host and Pathogen RNA-Seq Analysis Unravels Chicken Genes Potentially Involved in Resistance to Highly Pathogenic Avian Influenza Virus Infection.

Authors:  Albert Perlas; Jordi Argilaguet; Kateri Bertran; Raúl Sánchez-González; Miquel Nofrarías; Rosa Valle; Antonio Ramis; Martí Cortey; Natàlia Majó
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

3.  Annexin A2 regulates Mycoplasma bovis adhesion and invasion to embryo bovine lung cells affecting molecular expression essential to inflammatory response.

Authors:  Hui Zhang; Doukun Lu; Yiqiu Zhang; Gang Zhao; Abdul Raheem; Yingyu Chen; Xi Chen; Changmin Hu; Huanchun Chen; Liguo Yang; Aizhen Guo
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 4.  Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility.

Authors:  Hong-Long Ji; Runzhen Zhao; Sadis Matalon; Michael A Matthay
Journal:  Physiol Rev       Date:  2020-03-27       Impact factor: 37.312

Review 5.  Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?

Authors:  Fatma Elrashdy; Elrashdy M Redwan; Vladimir N Uversky
Journal:  Biomolecules       Date:  2020-09-11

6.  Evaluation of an innovative pediatric isolation (PI) bed using fluid dynamics simulation and aerosol isolation efficacy.

Authors:  Tiantian Liu; Yubing Guo; Xiaotang Hao; Mei Wang; Shicong He; Zhengshi Lin; Rong Zhou
Journal:  Build Simul       Date:  2021-03-04       Impact factor: 3.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.